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ucleostemin (NS) was identiﬁed as a stem cell–
and cancer cell–enriched nucleolar protein that
controls the proliferation of these cells. Here, we
report the mechanism that regulates its dynamic shuttling
between the nucleolus and nucleoplasm. The nucleolar
residence of nucleostemin involves a transient and a
long-term binding by the basic and GTP-binding do-
N
 
mains, and a dissociation mechanism mediated by the
COOH-terminal region. This cycle is propelled by the
GTP binding state of nucleostemin. We propose that a
rapid nucleostemin cycle is designed to translate extra-
and intra-cellular signals into the amount of nucleostemin
in the nucleolus in a bidirectional and fast manner.
 
Introduction
 
Stem cells are the building blocks during organogenesis. In
adults, they are responsible for replacing natural cell loss and
may promote recovery after injury. To maintain tissue homeo-
stasis and avoid tumor formation, it is critical to adjust the stem
cell division rate based on the supply of nutrients and mito-
gens, as well as the factors that signal the size of the tissue
(Bullough, 1965). However the molecular program regulating
the transition of stem cells between the actively dividing and
quiescent states remains unclear.
As a step in this direction, we have identified a novel
gene nucleostemin (NS) (Tsai and McKay, 2002) that is prefer-
entially expressed in the nucleoli of neural stem cells, embryonic
stem cells, and several cancer cell lines. NS is required for stem
cells and cancer cells to remain in the cell cycle, suggesting
that the rate of proliferation in these cells can be modulated by
the activity of NS. Given that NS is localized primarily in the
nucleolus where key features of cell growth including ribo-
some biogenesis occur, partitioning the amount of NS between
the nucleolar and nucleoplasmic compartments could provide a
way to regulate its activity. This idea is supported by previous
reports demonstrating a positive correlation between the size of
the nucleolus, the nucleolar activity, and the cell growth rate
(Derenzini et al., 1998, 2000). To date, little is known about the
molecular machinery that allows the cells to adjust their nucle-
olar size dynamically and reversibly.
The structure of the nucleolus is complex, and the analysis
of nucleolar functions is further complicated by the fact that
many of the nucleolar proteins are found both in the nucleolus
and the nucleoplasm (Chen and Huang, 2001; Dundr and Mis-
teli, 2002; Fox et al., 2002). In this manuscript, we investigate
the mechanism that controls the NS distribution. Our findings
suggest a GTP-driven cycling mechanism that modulates the
amount of NS in the nucleolus in a fast and bidirectional manner.
 
Results and discussion
 
NS shuttles between the nucleolus and 
the nucleoplasm
 
In addition to its predominant nucleolar distribution, NS is also
present at low levels in the nucleoplasm (Tsai and McKay, 2002).
To determine the mechanism controlling the NS localization, we
first examined if there is a dynamic exchange of NS between
these two compartments using the FRAP and inverse FRAP
(iFRAP)  approaches. Photobleaching experiments were con-
ducted on GFP-tagged NS protein (NS-GFP) in living cells using
time-lapse confocal microscopy (Phair and Misteli, 2000). U2 OS
cells or CHO cells were chosen because of their large, flat-
shaped nucleoli, resistance to phototoxicity, and their high levels
of endogenous NS expression. In addition to strongly labeled
nucleoli, the expressed NS-GFP also gave weak, diffuse signals
in the nucleoplasm, similar to the endogenous NS (Fig. 1 A1, NS
vs. NS-GFP). After actinomycin D (Act-D) treatment, an RNA
polymerase inhibitor that blocks transcription by intercalating be-
tween nucleotide base pairs and induces nucleolar reorganization
(Recher et al., 1971a,b), both the endogenous NS and NS-GFP
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were redistributed from the nucleolus to the nucleoplasm, with the
strongest signals surrounding the nucleolar region (Fig. 1 A2). The
total amount of NS-GFP protein appears higher than the endoge-
nous NS in the Act-D–treated cells, which may be due to the dif-
ferent promoters that drive their expression (cytomegalovirus vs.
the endogenous NS promoter). Based on the basal distribution and
the parallel changes in localization after Act-D treatment of wild-
type NS-GFP, as well as the growth arrest effect seen with the
mutated NS-GFP (Tsai and McKay, 2002), we used NS-GFP as a
living tracer to track the dynamic distribution of endogenous NS.
In the first study, cells with two nucleoli of comparable
size and intensity were photobleached in only one of their nucle-
oli by a short laser pulse that irreversibly quenched the GFP sig-
nal. The recovery of fluorescence in the bleached nucleolar area
(Fig. 1, B and C; label 1) reached 95% (y axis: 0.758) of the pla-
teau level (y axis: 0.783) within 39 s, reflecting the unbleached
nucleoplasmic NS-GFP moving into the nucleolus. The dissoci-
ation rate of NS from the nucleolus was measured by recording
the signal loss in the nonbleached nucleolus of the same cells
(iFRAP). 95% (y axis: 0.822) of the lost signals (y axis: from 1
to 0.813) (Fig. 1 B and C; label 2) were reached within 46 s after
photobleaching. Together, these results show that NS moves bi-
directionally between the nucleolus and the nucleoplasm. The
coordinated changes of fluorescence signals in the bleached and
nonbleached nucleoli and the fast kinetics of this process sup-
ports that these findings are not caused by protein synthesis or
by protein degradation as a result of photobleaching. Finally, the
fluorescent recovery rate of NS-GFP relative to the plateau re-
covery intensity remains constant regardless of the cell types
used to express it (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200409053/DC1). These data reveal a bidirec-
tional shuttling of NS between the nucleolus and nucleoplasm at
a rate that is fast and cell type independent.
 
GTP binding regulates the nucleolar 
targeting of NS
 
The structure of NS consists of an NH
 
2
 
-terminal basic (B) do-
main, followed by a coiled-coil (C) domain, two GTP-binding
motifs (G4: KXDL; G1: GXXXXGK[S/T]), a COOH-terminal
acidic domain (A), and an intermediate (I) region between the
G1 motif and the A-domain (Fig. 2 A, top). The GTP-binding
motifs of NS allow us to investigate how the GTP-binding state
of NS directly influences its nucleolar distribution. To this end,
we generated single amino acid mutation on the conserved res-
idues in the G4 or G1 motif (Fig. 2 A, bottom). G256 and G261
are conserved among NS and the Ras family. The N176I mu-
tation mimics the constitutive negative Ras mutant N116I
(Huang and Chuang, 2000). GTP-binding assays demonstrated
a specific retention of NS by the GTP-conjugated agarose, and
this interaction was blocked by preincubating NS with 10 mM
free GTP (Fig. 2 B) (Iismaa et al., 1997). This GTP-binding ca-
pacity of NS depends on the G1 motif, as single amino acid
substitution of the conserved G256 residue (Fig. 2 C, G256V)
decreased its GTP-binding ability to the control level (CT, the
COOH-terminal 188 aa polypeptide of NS lacking the G4 and
G1 motifs). These findings demonstrate a role of the G1 motif
in the GTP binding of NS. Just as the NH
 
2
 
-terminal B-domain
was required for the nucleolar distribution of NS (Fig. 2 D,
NS-dB), mutations in the G1 motif (G256V or G261V) also
blocked the nucleolar localization of NS, and created a diffuse
distribution in the nucleus. Mutation on the N176 residue,
which is not conserved in the small GTPase family, exhibited a
partial blocking effect on the nucleolar localization of NS.
Cells expressing the N176I mutant, while maintaining a nucle-
olus-predominant distribution, displayed higher nucleoplasmic
intensity than the wild-type NS, with a slight variation from
cells to cells (N176I-a, b). Based on these observations, we
Figure 1. NS cycles between the nucleolus and the nucleoplasm. (A) Endogenous NS and expressed NS-GFP fusion protein display a nucleolar distribution
in control cells (A1), and a nucleoplasmic distribution plus intense signals surrounding the nucleolar region in Act-D–treated CHO cells (A2). Inset: DAPI
nuclear staining of the same cells. Bars, 10  m. Time-sequenced images (B) and quantitative analyses (C) of FRAP (label 1) and iFRAP (label 2) on
NS-GFP–transfected CHO cells with two nucleoli. After subtraction of the background signal, the relative intensities were normalized to the nonbleached
signals in different cells, recorded in parallel, and shown in line 3 (C). Data were averaged over 20 cells in three independent experiments. Y-error bars
represent SEM, omitted at every other data point for clarity. Bar, 4  m. 
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concluded that N176 is not as critical in mediating the GTP
binding as the conserved G256 or G261, and used G256V as
the prototypical non-GTP-binding mutant for NS in the follow-
ing experiments. By contrast, deletions in the C-domain (NS-dC),
I-domain (NS-dI), or A-domain (NS-dA) did not affect the
static distribution of NS in the nucleolus. These results show
that both the B-domain and the wild-type GTP-binding domain
are required for the nucleolar targeting of NS.
Notably, despite the requirement of the GTP-binding mo-
tifs for the nucleolar localization of NS, B-domain alone was
sufficient to target the GFP protein to the nucleolus (Fig. 2 D,
Bas). This finding suggests an inhibitory mechanism that gates
the nucleolus-targeting activity of the full-length NS, and that it
is regulated by the GTP-binding state of NS. To map this region,
deletions of the B-, C-, I-, or A-domain were created in the
G256V background. Although dB(G256V) (Fig. 2 E1),
dC(G256V) (Fig. 2 E2), and dA(G256V) (Fig. 2 E4) remained
diffuse in the nucleoplasm, a deletion of the I-domain was able
to restore the nucleolar phenotype of the G256V mutant (Fig. 2
E3), indicating that the I-domain acts as the gating mechanism
that prevents the non-GTP-bound NS from moving into the nu-
cleolus. These results demonstrate that NS uses its GTP-binding
property as a molecular switch to control the transition between
the nucleolus- and the nucleoplasm-localized states, and this
process involves the interaction between the B-, GTP-binding,
and I-domains.
 
Mechanisms controlling the nucleolar 
residence of NS
 
Both the B-domain and the GTP-binding domain contribute to
the nucleolar localization of NS, as evidenced by the nucleolus-
exclusive distribution of the dB(G256V) double mutant (Fig. 2
E1) and the nucleolus-inclusive diffuse distribution of individ-
ual mutation (NS-dB and G256V, Fig. 2 D). To investigate
how the B-domain and the full-length NS protein differ in their
distribution, we compared the nucleolar residence time of the
B-domain alone and the full-length protein using a FRAP para-
digm where a 1.5-
 
 
 
m-diameter circle within the nucleolus
was bleached. Despite its apparent wild-type static distribution,
the B-domain alone has a much faster recovery kinetic than
the wild-type protein (Fig. 3, A, D, and E; Bas vs. NS-Wt).
2.5 s after photobleaching, the fluorescent recovery of Bas has
reached 87.6% of the prebleach level, compared with the
75.5% recovery of the full-length protein (P 
 
 
 
 0.001, 
 
n
 
 
 
 
 
 20).
Notably, a difference exists between the prebleached level and
the plateau recovery level. This may be accounted for by a de-
crease in the amount of fluorescence-active protein due to pho-
tobleaching. This notion is supported by a positive correlation
between the prebleach-plateau difference and the size of the
bleached area, seen by comparing the one-nucleolus (Fig. 1 C,
curve 1) and the partial-nucleolus bleaching paradigms (Fig. 3 A,
curve 2). This experiment suggests that the B-domain can
mediate a short-lived nucleolar targeting, likely of low affinity,
Figure 2. Nucleolar targeting of NS requires the B-domain and GTP-binding domain, and is blocked by the I-domain. (A) Top: a schematic diagram of
the NS protein structure (B: basic; C: coiled-coil; G4, G1: GTP-binding motifs; I: intermediate; A: acidic domains; black boxes: nuclear localization signals).
(Bottom) Sequences of single amino acid substitution on the conserved residues in the G4 and G1 motifs. (B) Purified GST fusion protein of wild-type NS
could bind GTP-agarose (left lane). This interaction was abolished by competition with 10 mM free GTP (right lane). (C) The role of the G1 motif in mediating
the GTP binding of NS was shown by a mutation in the G256 residue (G256V) that reduced its binding affinity to the background level as the COOH-
terminal NS control (CT). (D) The static distribution of NS mutants in U2 OS cells (NS-Wt: wild-type; NS-dB: B-domain deletion; NS-dC: C-domain deletion;
NS-dI: I-domain deletion; NS-dA: A-domain deletion; Bas: B-domain alone). Green: GFP-fused mutants; red: anti-B23 immunostaining of the same cell
(scaled to 60%). (E) Mapping the inhibitory domain that gates the nucleolus-targeting event mediated by the B-domain. A deletion of the I-domain (E3), but
not the B- (E1), C- (E2), or A- (E4) domain, can rescue the nucleolar phenotype of G256V mutation. Bars (D and E), 10  m. 
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and that there is another region in the NS protein required for
its long-term residence in the nucleolus.
To dissect the structural requirement for the high affinity
binding of NS in the nucleolus, FRAP experiments were
conducted on mutants that were deleted of the C-, I-, and
A-domains. A deletion in the domain required for the high af-
finity binding would decrease the retention time, whereas a de-
letion in the domain necessary for the dissociation from the high
affinity binding site would increase the retention time. Our data
showed that deletions of the I- and A-domains prolonged the re-
tention time of NS-GFP in the nucleoli. With the NS-dA mutant,
only 64.0% recovery of the prebleach intensity was reached at
2.5 s after photobleaching (Fig. 3, B, D, and E; NS-dA, P 
 
 
 
0.001, 
 
n
 
 
 
 
 
 20). The NS-dI signal in the bleached area had never
reached plateau during the 31.5-s recording period (Fig. 3, C
and E; NS-dI). A deletion of C-domain had no effect on the nu-
cleolar retention time of NS (Fig. 3 E, left table; NS-dC). These
results demonstrate that the I- and A-domains are required for
the exit from the high-affinity nucleolar state, and, by exclusion,
are consistent with a role of the GTP-binding domain in mediat-
ing the high affinity binding of NS to the nucleolus.
The data presented so far demonstrate that GTP binding is
required to release the I-domain from blocking the nucleolar tar-
geting of the B-domain, and is involved in the long-term nucle-
olar engagement of NS. To address the relationship between the
dissociation of guanine nucleotides in NS and the dissociation of
NS from its high affinity binding site in the nucleolus, we com-
pared the nucleolar retention time of dI(G256V) with that of
NS-dI (Fig. 3 C). dI(G256V) harbors the G256V mutation that
abolishes the GTP-binding ability of NS and is deleted of the
I-domain that would have prevented the nucleolar targeting of
the G256V mutant. Lacking the I-domain required for the dis-
sociation step, the FRAP recovery time for both NS-dI and
dI(G256V) was delayed compared with the wild-type NS. By
comparison, dI(G256V) mutant showed faster recovery than the
NS-dI mutant. At 30 s after photobleaching, dI(G256V) recovered
81.4% of the prebleached intensity, whereas the NS-dI mutant re-
covered 75% (Fig. 3 D, E, right table; P 
 
 
 
 0.05, 
 
n
 
 
 
 
 
 20). These
findings are consistent with the idea that guanine nucleotide disso-
ciation favors the dissociation of NS from the nucleolus.
 
Lowering intracellular GTP level 
decreases the nucleolar retention of NS
 
To further support the notion that guanine nucleotide dissocia-
tion correlates with the nucleolar exit of NS, we investigated if
changing the intracellular GTP level would affect the shuttling
kinetics of NS. To lower the intracellular GTP level, myco-
phenolic acid (MPA), which inhibits the rate-limiting enzyme
inositide 5
 
 
 
-monophosphate dehydrogenase (IMPDH) of de
novo guanine nucleotide biosynthesis (Majumdar et al., 1995;
Olah et al., 1988), was applied to U2 OS cells transfected with
NS-GFP. Photobleaching experiments were conducted in which
3-
 
 
 
m-diameter nucleoli were bleached and recorded for signal
recovery over a 67-s period. The FRAP results revealed short-
ened nucleolar residence time of NS in cells treated with 40 
 
 
 
M
MPA. At 10 s after photobleaching, the fluorescent signal re-
covered 80% of the prebleach level in the 40-
 
 
 
M MPA-treated
cells, whereas control cells reached only 72% (Fig. 4, A and C;
P 
 
 
 
 0.001). A clear reduction in the amount of endogenous NS
(red) or NS-GFP (green) in the nucleolus was also seen in the
MPA-treated cells (Fig. 4 B1) compared with the untreated cells
(B2). These MPA treatment results provide consistent evidence
Figure 3. The long-term association of NS in the nucleolus is regulated by the I- and A-domains, and the binding of guanine nucleotide. (A and B) Quantitative
data of FRAP analyses of the B-domain alone (Bas, trace 1), the wild-type NS (NS-Wt, trace 2), and the A-domain deletion (NS-dA, trace 3) in CHO cells.
Y-error bars represent SEM and are omitted at every other data point for clarity. For comparison, Bas and NS-dA were shown in B and A in gray without
error bars. (C) FRAP analyses of dI(G256V) (trace 2) and NS-dI (trace 3), compared with the wild-type NS (trace 1). Dotted lines in A–C indicate the
points of analysis. (D) Time-sequenced FRAP images of NS-Wt, Bas, and NS-dA mutants before and after photobleaching. Bar, 4  m. A 1.5- m-diameter
circle (marked by asterisks) within the nucleolus was bleached and the signal recovery was recorded over a period of 31.5 s. (E) T-test analyses of the FRAP
results of wild-type and mutant NS-GFP fusion protein (mean   SEM, n   20) were conducted at 2.5 s (left) or 30 s (right) after photobleaching. 
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that supports our mutagenesis findings, and suggest that the NS
cycling receives regulatory inputs from intracellular signals.
 
The FRAP rate of NS is distinctly 
different from a non-GTP-binding 
nucleolar protein, B23
 
Previous work has shown that lowering the GTP level could al-
ter the distribution of a non-GTP-binding nucleolar protein,
B23, which also displayed a dynamic property to shuttle be-
tween the nucleolus and nucleoplasm (Finch et al., 1993; Chen
and Huang, 2001). In the next experiment, we investigate the
difference in the cycling kinetics between NS and B23. FRAP
results demonstrated that the exchange rate for B23 was dis-
tinctively slower than that of NS (Fig. 5 A). At 2.5 and 5 s after
photobleaching, B23 reached only 53.0% (
 
 
 
 1.8; mean 
 
 
 
SEM) and 63.6% (
 
 
 
 1.8) of its prebleach level, whereas the
wild-type NS returned to 63.0% (
 
 
 
 1.1) and 72.2% (
 
 
 
 0.9) of the
prebleach intensity at the same time points (P 
 
 
 
 0.001, 
 
n
 
 
 
 
 
 24).
The slower FRAP rate of the non-GTP-binding B23 compared
with the GTP-binding NS may reflect different regulatory
mechanisms controlling the dynamic distribution of these two
proteins, or suggest that NS acts upstream of B23.
In this manuscript, we show that NS shuttles between four
different states in the nucleus (Fig. 5 B). In the nucleoplasm, the
non-GTP-bound state of NS is prevented from being localized
to the nucleolus by the I-domain, and this inhibitory mechanism
is released upon GTP binding. The nucleolus-bound NS exhib-
its a fast FRAP rate when mediated by the B-domain and a slow
FRAP rate when mediated by the GTP-binding domain. It is un-
clear if these two nucleolus-engaged states take place sequen-
tially or cooperatively. Finally, the dissociation of the nucleo-
lus-engaged NS is mediated by the I- and A-domains, and may
be triggered by the dissociation of guanine nucleotide. The tran-
sition of NS between these four different molecular states in the
nucleus constitutes a cycling machinery that operates in a rapid
and dynamic manner. With the identification of several putative
GTPases in the nucleolus (Racevskis et al., 1996; Jensen et al.,
2003; Kallstrom et al., 2003) and the GTP effect on the non-
GTP-binding B23 (Finch et al., 1993), this proposed GTP-
driven mechanism provides a molecular framework that may
Figure 4. The effect of lowering the intracellular GTP on the static and dynamic distribution of NS. (A) FRAP analyses of NS-GFP in U2 OS cells treated
with 40  M MPA for 24 h (trace 1) or nontreated cells (trace 2). Photobleaching was administered to 3- m-diameter nucleoli. After subtraction of the
background signal, the relative intensities were normalized to the nonbleached signals in different cells, and averaged over 20 cells in three independent
experiments. Y-error bars were omitted at every other data points for clarity. Dotted lines indicate the points of analysis. (B) The static distribution of endog-
enous NS (red), NS-GFP (green), and DAPI nuclear staining (inset) in cells treated with MPA (B1) or untreated cells (B2). Bar, 10  m. (C) T-tests were
conducted at 5, 10, 15, and 20 s after photobleaching to compare between the FRAP rates of MPA-treated cells and the nontreated cells (mean   SEM).
Figure 5. FRAP comparison of NS and B23,
and a regulatory model for the dynamic distri-
bution of NS. (A) The nucleolar residence time
of NS is shorter than the non-GTP-binding B23.
Photobleaching experiments were conducted
as described in Fig. 3. Dotted lines indicate the
points of analysis. (B) A multistep, GTP-driven
model for the regulation of NS distribution. The
three rectangular boxes indicate the cell mem-
brane, the nuclear membrane, and the nucleo-
lus (outside-in). The filled circles and square
represent the GTP (G)-bound and unbound NS.
In the nucleoplasm, the GTP-bound NS is re-
leased of the inhibitory activity mediated by the
I-domain and can be targeted to the nucleolus.
Binding to the nucleolus through the B-domain
alone is short lived (SE). The long-term engage-
ment (LE) of NS in the nucleolus involves the
GTP-binding domain. Its release requires the
I- and A-domains, and may be triggered by
the dissociation of guanine nucleotides. 
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explain how some nucleolar proteins move between the nucle-
olar and nucleoplasmic compartments dynamically.
Such a dynamic system also generates a bidirectional,
fast, and sensitive measurement to control the amount of NS
engaged in the nucleolus. By monitoring the targeting probabil-
ity and dissociation kinetics, this mechanism can be used to
translate the intra- and extra-cellular growth signals into the
amount of NS in the nucleolus as a way to dynamically control
cell proliferation (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200409053/DC1). In addition, it also allows
nucleolar proteins, such as Werner’s syndrome protein, DNA
topoisomerase, and NS (Blander et al., 1999; Gobert et al.,
1999; Tsai and McKay, 2002; Horn and Vousden, 2004), the
opportunity to interact with nucleoplasmic proteins such as p53
under physiological conditions. Our findings that the FRAP
kinetics of NS remains the same in both p53-wild-type and
p53-null cell lines (Fig. S1) indicate that the dynamic distribu-
tion of NS is not controlled by p53, but suggest a possibility
that it may be involved in controlling the amount of p53 in the
active transcriptional sites within the nucleolus (Rubbi and
Milner, 2000). Further understanding of the NS machinery and
the signaling pathways that control its activity will help eluci-
date the molecular mechanism that gates the transition of stem
cells between the mitotically active and quiescent states in a
fast and reversible way.
 
Materials and methods
 
Deletion and point mutation of NS-GFP fusion constructs
 
Deletions and point mutations were introduced by stitching PCR reactions.
Both strands of mutagenic primers were synthesized using NS-GFP as the
template and paired with respective flanking primers for PCR reactions.
The resulting PCR fragments were used as the template for the next round
of PCR with only the flanking primers. The final products were restricted,
subcloned into expression vector (pCIS), and confirmed by sequencing.
 
FRAP and iFRAP
 
Cells grown in LabTek II chamber slides (Nalgene) were transfected with
0.6 
 
 
 
g plasmid DNA complexed with 3 
 
 
 
l LipofectAMINE 2000 reagent
in 1.2 ml Opti-MEM 1 d before the measurement. The photobleaching ex-
periments were performed on a confocal microscope (model 510; Carl
Zeiss MicroImaging, Inc.) with a 63
 
 
 
 plan-apochromat oil objective
(Phair and Misteli, 2000). The GFP signal was excited with the 488-nm ar-
gon laser and emission was monitored above 505 nm. Cells were main-
tained at 35
 
 
 
C with a heat blower. The whole nucleolar region or a small
area of the nucleolus was bleached using a short laser pulse administered
at 95% of the power for three iterations, with all experiments ensured to
achieve 70–80% bleaching of the original intensity. The recovery of sig-
nal in the bleached area (FRAP) was monitored. The relative fluorescence
intensity was normalized to the nonbleached signal after subtraction of the
background signal. Values are averages of at least 20 cells from three in-
dependent experiments. The iFRAP paradigm was designed where cells
with two nucleoli of comparable size and intensity were chosen and one
nucleolus was bleached. The loss of fluorescence from the unbleached nu-
cleoli was determined as described for the FRAP paradigms.
 
GTP-binding assay
 
The GTP-binding assays were conducted as described in Iismaa et al.
(1997) with 1 
 
 
 
g purified proteins and 80 
 
 
 
l GTP-agarose (2.2 
 
 
 
mol/ml).
After extensive wash procedure, the amount of bound protein was de-
tected by Western blot.
 
Online supplemental material
 
Fig. S1: FRAP rate comparison of the wild-type NS-GFP protein in different
cell lines. Fig. S2: serum deprivation has a mild effect on the static distribu-
tion of NS and its FRAP recovery rate relative to the recovery plateau. Fig.
S3: the distribution of NS in response to aluminum fluoride (AlF
 
4
 
 
 
) treatments.
Online supplemental material available at http://www.jcb.org/cgi/
content/full/jcb.200409053/DC1.
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